Kolexia
Jaffrelot Marion Oncologie médicale
Jaffrelot Marion
Oncologie médicale
Oncopole Toulouse
Toulouse, France
37 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs colorectales Instabilité des microsatellites Métastase tumorale Tumeurs colorectales héréditaires sans polypose Carcinomes Tumeurs du péritoine Sarcomes Aneuploïdie Rhabdomyosarcome

Collaborateurs

Voir plus
Guimbaud Rosine
Guimbaud Rosine
Hôpital Rangueil, Toulouse, France
Fares Nadim
Fares Nadim
Hôpital Rangueil, Toulouse, France
Alouani Emily
Alouani Emily
Hôpital Rangueil, Toulouse, France
Rivera Pascale
Rivera Pascale
Hôpital Rangueil, Toulouse, France

Industries

Voir plus
Servier
9 collaboration(s)
Dernière en 2023
Merck-Serono
4 collaboration(s)
Dernière en 2023
INTER-VIEW PARTNERS FRANCE
2 collaboration(s)
Dernière en 2023
Ipsen
1 collaboration(s)
Dernière en 2021

Dernières activités

Voir plus
BACAP-2: Anatomical-Clinical Base of Adenocarcinoma Pancreatic
Essai Clinique (CHU Toulouse)   20 novembre 2023
Special features of sarcomas developed in patients with Lynch syndrome: A systematic review.
Critical reviews in oncology/hematology   08 juin 2023
Efficacy of immunotherapy in mismatch repair-deficient advanced colorectal cancer in routine clinical practice. An AGEO study.
ESMO open   25 mai 2023
The hereditary N363K POLE exonuclease mutant extends PPAP tumor spectrum to glioblastomas by causing DNA damage and aneuploidy in addition to increased mismatch mutagenicity.
NAR cancer   11 mars 2023
CINSARC signature outperforms gold-standard TNM staging and consensus molecular subtypes for clinical outcome in stage II-III colorectal carcinoma.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc   06 octobre 2022
FOLFIRI plus BEvacizumab or aFLIbercept after FOLFOX-bevacizumab failure for COlorectal cancer (BEFLICO): An AGEO multicenter study.
International journal of cancer   14 juillet 2022
Oncologie médicale digestive - CHU de Toulouse
CHU Toulouse   09 juin 2022
Heterogeneity of Mismatch Repair Status and Microsatellite Instability between Primary Tumour and Metastasis and Its Implications for Immunotherapy in Colorectal Cancers.
International journal of molecular sciences   17 avril 2022
An unusual phenotype occurs in 15% of mismatch repair-deficient tumors and is associated with non-colorectal cancers and genetic syndromes.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc   20 septembre 2021
462P Heterogeneity of mismatch repair status between primary tumors and matched metastases in metastatic colorectal cancer
Abstract Book of the ESMO Congress 2021, 16 – 21 September 2021   01 septembre 2021